LEXICON PHARMACEUTICALS, INC. — Director's Dealing 2021

Aug 3, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LEXICON PHARMACEUTICALS, INC. (LXRX)
CIK: 0001062822
Period of Report: 2021-08-02

Reporting Person: Granowitz Craig B (SVP, Chief Medical Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-08-02	Stock Option (Right to Buy)	$3.54	A	250000	Acquired	2031-08-02	Common Stock (250000)	Direct

Footnotes

F1: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant (8/2/2022) and vests 1/48th per month for each month of service thereafter.